HomeAI · summaries
Storia in 2 fonti
Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda
Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda
Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda
- ·
benzinga.com
Jury Hits Takeda With $885 Million Antitrust Verdict - Takeda Pharmaceutical Co (NYSE:TAK)
Takeda faces nearly $885 million jury verdict in AMITIZA antitrust case and plans post-trial motions and appeal.